Jennifer Litton, Vice President of Clinical Research and Professor of Breast Medical Oncology at MD Anderson Cancer Center, shared on LinkedIn:
“Thank you very much to Commissioner Makary, Dr. Jeremy Walsh and colleagues from the FDA, UPenn and our industry partners for bringing us together to pilot new ways to bring clinical trials up to speed. The overall goal is to get promising new therapies- still through rigorous clinical trials- to patients faster.
When you need the hope of a new therapy you want that hope as soon as possible. Link to podcast.”
Other articles about FDA on OncoDaily.